ג'נואט 50/850 מ"ג טבליות ישראל - עברית - Ministry of Health

ג'נואט 50/850 מ"ג טבליות

merck sharp & dohme israel ltd - metformin hydrochloride 850 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

נובוגרד 1 מ"ג/500 מ"ג ישראל - עברית - Ministry of Health

נובוגרד 1 מ"ג/500 מ"ג

novo nordisk ltd - metformin hydrochloride 500 mg; repaglinide 1 mg - tablets - metformin - novogard is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 mellitus who are already treated with a meglitinide and metformin hcl or who have inadequate glycemic control on a meglitinide alone or metformin hcl alone.

נובוגרד 2 מ"ג/500 מ"ג ישראל - עברית - Ministry of Health

נובוגרד 2 מ"ג/500 מ"ג

novo nordisk ltd - metformin hydrochloride 500 mg; repaglinide 2 mg - tablets - metformin - novogard is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 mellitus who are already treated with a meglitinide and metformin hcl or who have inadequate glycemic control on a meglitinide alone or metformin hcl alone.

אבנדמט 4 מ"ג/1000 מ"ג ישראל - עברית - Ministry of Health

אבנדמט 4 מ"ג/1000 מ"ג

glaxo smith kline (israel) ltd - metformin hydrochloride 1000 mg; rosiglitazone as maleate 4 mg - tablets - metformin and rosiglitazone - avandamet is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus : as dual combination therapy in patients who are already treated with combination rosiglitazone and metformin or who are not adequately controlled on metformin alone or in triple oral therapy with sulphonylurea in patients with insufficient glycaemic control despite dual oral therapy with their maximally tolerated dose of metformin and a sulphonylurea.

טנסופריל 10 מ"ג ישראל - עברית - Ministry of Health

טנסופריל 10 מ"ג

merck sharp & dohme israel ltd - lisinopril as dihydrate 10 mg - tablets - lisinopril - hypertension: tensopril is indicated for the treatment of essentioal hypertension and renovascular hypertension. tensopril may be used alone as initial therapy or concomitantly with other classes of antihypertensive agents. congestive heart failure: tensopril is indicated as adjunctive therapy in the management of heart failure in patients who are not responding adequately to diuretics and digitalis. acute myorardial infarction: tensopril is indicated for the treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction to improve survival.

טנסופריל 20 מ"ג ישראל - עברית - Ministry of Health

טנסופריל 20 מ"ג

merck sharp & dohme israel ltd - lisinopril as dihydrate 20 mg - tablets - lisinopril - hypertension: tensopril is indicated for the treatment of essential hypertension and renovascular hypertension. tensopril may be used alone as initial therapy or concomitantly with other classes of antihypertensive agents. congestive heart failure: tensopril is indicated as adjunctive therapy in the management of heart failure in patients who are not responding adequately to diuretics and digitalis. acute myocardial infarction: tensopril is indicated for the treatment of hemodynamically stable patients within 24 hous of acute myocardial infarction to improve survival.

טנסופריל 5 מ"ג ישראל - עברית - Ministry of Health

טנסופריל 5 מ"ג

merck sharp & dohme israel ltd - lisinopril as dehydrate 5 mg - tablets - lisinopril - hypertension: tensopril is indicated for the treatment of essential hypertension and renovascular hypertension.tensopril may be used alone as initial therapy, or concomitantly with other classes of antihypertensive agents. congestive heart failure: tensopril is indicated as adjunctive therapy in the management of heart failure in patients who are not responding adequately to diuretics and digitalis. acute myocardial infarction: tensopril is indicated for the treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction to improve survival.

טרנטל 400 ישראל - עברית - Ministry of Health

טרנטל 400

sanofi - aventis israel ltd - pentoxifylline 400 mg - tablets prolonged release - pentoxifylline - for the improvement of blood flow in the peripheral blood vessels.

לוקובורין ישראל - עברית - Ministry of Health

לוקובורין

abic ltd. - calcium folinate 15 mg - tablets - detoxifying agents for antineoplastic treatment - counteracts the action of folic acid antagonists. improves blood picture in megaloblastic anemias due to folate deficiency. as leucovorin- fluorouracil combination chemotherapy in cancer.

יוקריאס 50/850 מ"ג ישראל - עברית - Ministry of Health

יוקריאס 50/850 מ"ג

novartis pharma services ag - metformin hydrochloride 850 mg; vildagliptin 50 mg - film coated tablets - metformin - eucreas is indicated in the treatment of type 2 diabetes mellitus:• eucreas is indicated in the treatment of type 2 diabetes patients who are unable to achieve sufficient glycemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.• eucreas is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea.• eucreas is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.